According to G1 Therapeutics 's latest financial reports the company's current EPS (TTM) is -$2.02. In 2022 the company made an earnings per share (EPS) of -$4.79 an increase over its 2021 EPS that were of -$5.02.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$1.93 | -59.71% |
2022 | -$4.79 | -4.53% |
2021 | -$5.02 | 34.22% |
2020 | -$3.74 | -19.33% |
2019 | -$4.64 | 26.36% |
2018 | -$3.67 | -10.06% |
2017 | -$4.08 | 68.91% |
2016 | -$2.41 |